Effects of proteasome inhibitors MG132, ZL3VS and AdaAhx3L3VS on protein metabolism in septic rats

. 2004 Dec ; 85 (6) : 365-71.

Jazyk angličtina Země Anglie, Velká Británie Médium print

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid15566433

Proteasome inhibitors are novel therapeutic agents for the treatment of cancer and other severe disorders. One of the possible side effects is influencing the metabolism of proteins. The aim of our study was to evaluate the influence of three proteasome inhibitors MG132, ZL(3)VS and AdaAhx(3)L(3)VS on protein metabolism and leucine oxidation in incubated skeletal muscle of control and septic rats. Total proteolysis was determined according to the rates of tyrosine release into the medium during incubation. The rates of protein synthesis and leucine oxidation were measured in a medium containing L-[1-(14)C]leucine. Protein synthesis was determined as the amount of L-[1-(14)C]leucine incorporated into proteins, and leucine oxidation was evaluated according to the release of (14)CO(2) during incubation. Sepsis was induced in rats by means of caecal ligation and puncture. MG132 reduced proteolysis by more than 50% and protein synthesis by 10-20% in the muscles of healthy rats. In septic rats, proteasome inhibitors, except ZL(3)VS, decreased proteolysis in both soleus and extensor digitorum longus (EDL) muscles, although none of the inhibitors had any effect on protein synthesis. Leucine oxidation was increased by AdaAhx(3)L(3)VS in the septic EDL muscle and decreased by MG132 in intact EDL muscle. We conclude that MG132 and AdaAhx(3)L(3)VS reversed protein catabolism in septic rat muscles.

Zobrazit více v PubMed

Bailey JL, Wang X, England BK, Price SR, Ding X, Mitch WE. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin–proteasome pathway. J. Clin. Invest. 1996;97:1447–1453. PubMed PMC

Chai J, Wu Y, Sheng ZZ. Role of ubiquitin–proteasome pathway in skeletal muscle wasting in rats with endotoxemia. Crit. Care Med. 2003;31:1802–1807. PubMed

Davis NB, Taber DA, Ansari RH, et al. Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium study. J. Clin. Oncol. 2004;22:115–119. 10.1200/JCO.2004.07.165. PubMed DOI

Di Napoli M, Papa F. MLN-519. Millennium/PAION. Curr. Opin. Investig. Drugs. 2003;4:333–341. PubMed

Drexler HC. Programmed cell death and the proteasome. Apoptosis. 1998;3:1–7. 10.1023/A:1009604900979. PubMed DOI

Fang CH, Wang JJ, Hobler S, Li BG, Fischer JE, Hasselgren PO. Proteasome blockers inhibit protein breakdown in skeletal muscle after burn injury in rats. Clin. Sci. (Colch.) 1998;95:225–233. 10.1042/CS19980092. PubMed DOI

Fischer D, Gang G, Pritts T, Hasselgren PO. Sepsis-induced muscle proteolysis is prevented by a proteasome inhibitor in vivo. Biochem. Biophys. Res. Commun. 2000;270:215–221. 10.1006/bbrc.2000.2398. PubMed DOI

Glickman MH, Ciechanover A. The ubiquitin– proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 2002;82:373–428. PubMed

Hasselgren PO, James JH, Benson DW, et al. Total and myofibrillar protein breakdown in different types of rat skeletal muscle: effects of sepsis and regulation by insulin. Metabolism. 1989;38:634–640. 10.1016/0026-0495(89)90100-5. PubMed DOI

Hershko A, Ciechanover A, Varshavsky A. Basic Medical Research Award. The ubiquitin system. Nat. Med. 2000;6:1073–1081. 10.1038/80384. PubMed DOI

Hobler SC, Tiao G, Fischer JE, Monaco J, Hasselgren PO. Sepsis-induced increase in muscle proteolysis is blocked by specific proteasome inhibitors. Am. J. Physiol. 1998;274:R30–R37. PubMed

Holeček M. Leucine metabolism in fasted and tumor necrosis factor-treated rats. Clin. Nutr. 1996;15:91–93. PubMed

Holeček M, Šprongl L, Skopec F, Andrýs C, Pecka M. Leucine metabolism in TNF-alpha-and endotoxin-treated rats: contribution of hepatic tissue. Am. J. Physiol. 1997;273:E1052–E1058. PubMed

Kessler BM, Tortorella D, Altun M, et al. Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic beta-subunits. Chem. Biol. 2001;8:913–929. 10.1016/S1074-5521(01)00069-2. PubMed DOI

Kisselev AF, Goldberg AL. Proteasome inhibitors: from research tools to drug candidates. Chem. Biol. 2001;8:739–758. 10.1016/S1074-5521(01)00056-4. PubMed DOI

Lee DH, Goldberg AL. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 1998;8:397–403. 10.1016/S0962-8924(98)01346-4. PubMed DOI

Lombardo YB, Thamotharan M, Bawani SZ, Paul HS, Adibi SA. Posttranscriptional alterations in protein masses of hepatic branched-chain keto acid dehydrogenase and its associated kinase in diabetes. Proc. Assoc. Am. Physicians. 1998;110:40–49. PubMed

Lowry OH, Rosebrough AL, Farr AL, Randal R. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951;193:265–275. PubMed

Mack PC, Davies AM, Lara PN, Gumerlock PH, Gandara DR. Integration of the proteasome inhibitor PS-341 (VELCADE) into the therapeutic approach to lung cancer. Lung Cancer. 2003;41:S89–S96. 10.1016/S0169-5002(03)00149-1. PubMed DOI

Mitch WE, Price SR. Mechanisms activating proteolysis to cause muscle atrophy in catabolic conditions. J. Ren. Nutr. 2003;13:149–152. 10.1053/jren.2003.50019. PubMed DOI

Nawabi MD, Block KP, Chakrabarti MC, Buse MG. Administration of endotoxin, tumor necrosis factor, or interleukin 1 to rats activates skeletal muscle branched-chain alpha-keto acid dehydrogenase. J. Clin. Invest. 1990;85:256–263. PubMed PMC

Pedersen PV, Warner BW, Bjornson HS, et al. Hemodynamic and metabolic alterations during experimental sepsis in young and adult rats. Surg. Gynecol. Obstet. 1989;168:148–156. PubMed

Richardson PG, Hideshima T, Anderson KC. Bortezomib (PS-341): a novel, first-in-class proteasome inhibitor for the treatment of multiple myeloma and other cancers. Cancer Control. 2003;10:361–369. PubMed

Šafránek R, Holeček M, Kadlcíková J, et al. Effect of acute acidosis on protein and amino acid metabolism in rats. Clin. Nutr. 2003;22:437–443. 10.1016/S0261-5614(03)00041-4. PubMed DOI

Tawa NE, Jr, Odessey R, Goldberg AL. Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. J. Clin. Invest. 1997;100:197–203. PubMed PMC

Tiao G, Fagan JM, Samuels N, et al. Sepsis stimulates non-lysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. J. Clin. Invest. 1994;94:2255–2264. PubMed PMC

Tiao G, Lieberman M, Fischer JE, Hasselgren PO. Intracellular regulation of protein degradation during sepsis is different in fast-and slow-twitch muscle. Am. J. Physiol. 1997;272:R849–R856. PubMed

Tsujinaka T, Homma T, Ebisui C, et al. Modulation of muscle protein metabolism in disseminated intravascular coagulation. Eur. Surg. Res. 1995;27:227–233. PubMed

Waalkes TP, Udenfriend S. A fluorometric method for the estimation of tyrosine in plasma and tissues. J. Lab. Clin. Med. 1957;50:733–736. PubMed

Zamir O, Hasselgren PO, Frederick JA, Fischer JE. Is the metabolic response to sepsis in skeletal muscle different in infants and adults? An experimental study in rats. J. Pediatr. Surg. 1992;27:1399–1403. 10.1016/0022-3468(92)90185-A. PubMed DOI

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Effects of beta-hydroxy-beta-methylbutyrate supplementation on skeletal muscle in healthy and cirrhotic rats

. 2019 Jun ; 100 (3) : 175-183. [epub] 20190718

Muscle wasting and branched-chain amino acid, alpha-ketoglutarate, and ATP depletion in a rat model of liver cirrhosis

. 2018 Dec ; 99 (6) : 274-281. [epub] 20190113

Effects of branched-chain amino acids on muscles under hyperammonemic conditions

. 2018 Nov ; 74 (4) : 523-530. [epub] 20180730

Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions

. 2017 Aug ; 8 (4) : 529-541. [epub] 20170510

Acute effects of phenylbutyrate on glutamine, branched-chain amino acid and protein metabolism in skeletal muscles of rats

. 2017 Jun ; 98 (3) : 127-133. [epub] 20170616

Alterations in protein and amino acid metabolism in rats fed a branched-chain amino acid- or leucine-enriched diet during postprandial and postabsorptive states

. 2016 ; 13 () : 12. [epub] 20160211

Muscle wasting in animal models of severe illness

. 2012 Jun ; 93 (3) : 157-71. [epub] 20120508

The effect of new proteasome inhibitors, belactosin A and C, on protein metabolism in isolated rat skeletal muscle

. 2009 Jun ; 65 (2) : 137-46.

Protein metabolism in slow- and fast-twitch skeletal muscle during turpentine-induced inflammation

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...